News
The drug manufacturer will no longer study and test danuglipron after a participant in a clinical trial was injured.
Results that may be inaccessible to you are currently showing.
Hide inaccessible resultsResults that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback